The Trump administration quietly spent billions in hospital funds on Operation Warp Speed
WASHINGTON — The Trump administration quietly took around $10 billion from a fund meant to…
Category: Biotech
STAT+: A surprise FDA advisory panel imperils Fibrogen’s experimental anemia pill
Fibrogen was expecting the Food and Drug Administration to complete a review of its experimental…
STAT+: A nascent state effort would tax drug makers for not providing clinical evidence for price hikes
In a bid to control the cost of medicines, lawmakers in two states — Hawaii…
.jpg)
STAT+: New Mexico attorney general accuses Gilead of blocking competition to its HIV medicines
The New Mexico attorney general has filed a lawsuit against Gilead Sciences (GILD) and two…
New research finds evictions during pregnancy are tied to adverse birth outcomes
Babies born to people evicted during pregnancy are more likely to have lower birth weights…
STAT+: Pharmalittle: J&J Covid-19 vaccine supply will be uneven; pandemic ushers in a ‘golden age of vaccinology’
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
STAT Madness has begun. Vote for the best innovations in biomedicine
The first round of voting begins Monday, March 1 at 6 a.m. EDT and is…
Opinion: Why drug prescriptions should include diagnoses
The Covid-19 pandemic is teaching us many tragic lessons along with some instructive ones, like…
STAT+: Janet Woodcock revolutionized the way the FDA reviews cancer drugs, inspiring her supporters and raising concerns for detractors
WASHINGTON — In 2000, the Food and Drug Administration approved just three cancer drugs. Last…
Johnson & Johnson’s Covid-19 vaccine to start shipping soon, but early supply could be uneven
WASHINGTON — Health care providers will begin receiving the first 3.9 million doses of Johnson…
Opinion: Remembering Bernard Lown: physician, activist, Nobel Peace Prize winner
I have long thought that there are three types of physician. The first is fascinated…
FDA authorizes Johnson & Johnson’s single-dose Covid-19 vaccine
The Food and Drug Administration on Saturday issued an emergency authorization for a Covid-19 vaccine…
Opinion: Superspreaders take note: 7 chances to keep up the good work before herd immunity sets in
Like so many other Americans, we were green with envy as we watched football fans…
STAT+: Cigna’s Evernorth to acquire telehealth company MDLive
Riding a wave of pandemic-fueled momentum for virtual care, Cigna subsidiary Evernorth is acquiring telehealth…
‘We’re not there yet’: Biden officials issue somber warning about uptick in Covid-19 cases
WASHINGTON — Biden administration officials on Friday warned of a “very concerning” uptick in Covid-19…
Opinion: Sen. Rand Paul misunderstands transgender medicine. Here’s the truth
In a tense exchange on Thursday during the Senate confirmation hearing of Dr. Rachel Levine,…
STAT+: Pharmalittle: Sarepta wins another FDA nod; Germans balk at AstraZeneca vaccine
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
Tracking an FDA advisory panel’s meeting on J&J’s Covid-19 vaccine
Now it’s Johnson & Johnson’s turn. A panel of outside experts is meeting Friday for…
STAT+: Sen. Cassidy explains why he’s backing a bill aimed at drug-resistant bacteria
The Covid-19 pandemic has shown the damage that an uncontrolled infectious disease can cause society….
Here are the contenders for STAT Madness 2021. Voting begins Monday
For science, 2020 was a year like no other, as labs around the world shifted…
Opinion: Primary care practices could be the Biden administration’s secret weapon in the fight against Covid-19
For a small-town physician, being given a supply of the Covid-19 vaccine can make a…
Andrew Cuomo’s Covid-19 nursing home fiasco shows the ethical perils of pandemic policymaking
WASHINGTON — The humbling of New York Gov. Andrew Cuomo on pandemic policy has been…
After allegations of racism and sexism, some applicants remove Tulane from residency rankings
With time running out for their medical residency decisions, some applicants say they’re taking Tulane…
STAT+: The vial is not half empty: New report lays out ways to address the issue of discarded drugs
File this under ‘Waste not, want not.’ In response to the cost of medicines, a…
Listen: Covid vaccines for teens, Novavax’s remarkable rise, and the future of HHS
Why can’t kids get Covid-19 vaccines? Is there hope for biotech penny stocks? And when…
Sarepta wins new drug approval for patients with Duchenne muscular dystrophy, its third marketed treatment
The Food and Drug Administration on Thursday approved a new medicine from Sarepta Therapeutics that…
Opinion: Discarded drugs: a wasteful and costly problem that requires whole-of-government approaches
Controlling the rising costs of pharmaceuticals, particularly those administered by physicians, has been a top…
Virtual Event: The pandemic’s toll on mental health
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. …
STAT+: Pharmalittle: Moderna proceeds with a vaccine trial to combat Covid-19 variant; who will be the next FDA commish?
Top of the morning to you, and a fine one it is. Once again, clear…
STAT+: A U.S. court ruling may force biologics makers to review patent protections
In a decision with broad implications for the pharmaceutical industry, a U.S. appeals court recently…
STAT+: CytoDyn has data on its highly touted experimental Covid treatment. Investors and patients don’t
CytoDyn CEO Nader Pourhassan has been uncharacteristically quiet this week about a completed clinical trial…
GlaxoSmithKline Covid-19 drug falls short in trial, but may benefit older patients
An experimental rheumatoid arthritis drug being developed by GlaxoSmithKline failed to show a significant benefit…
Is more simply better? Why Pfizer thinks a booster of its Covid vaccine might work against new variants
Could the solution to emerging variants of the coronavirus that causes Covid-19, some of which…
Opinion: CDC estimated a one-year decline in life expectancy in 2020. Not so — try five days
The Centers for Disease Control and Prevention made headlines last week when it announced that…
‘We need to get in the room’: Hospital chaplains struggle to balance Covid safety with patients’ spiritual needs
Infection fears have never slowed down Rev. Moneka Thompson. For more than 10 years, she’s…
‘A full court press’: Banking on tech backup, CDC launches nationwide VaccineFinder tool
On Wednesday, federal officials quietly opened up access to VaccineFinder, a site that allows the…
Challenging the link between statins and muscle pain, patients report no difference in aches when taking drug or placebo
Statins — among the most successful drugs ever developed — prevent deaths from heart attacks…
Pfizer-BioNTech vaccine performs as well in the real world as in clinical trials, new study concludes
Pfizer and BioNTech’s Covid-19 vaccine performed as well in the real world as it did…
Moderna ready to test version of Covid-19 vaccine aimed at worrisome variant
Moderna is pressing forward with a modified version of its Covid-19 vaccine meant to protect…
STAT+: Once again, the credit outlook for the pharmaceutical industry is negative
For the eighth consecutive year, the credit outlook for the pharmaceutical industry is negative and…
Opinion: Listen: Catherine Mezzacappa and Ruth Faden on vaccinations and pregnancy
This week on “The First Opinion Podcast,” I talk with Catherine Mezzacappa and Ruth Faden…
STAT+: ‘It looks like a spaghetti bowl’: Scientists reveal a precise structure in a fabled worm’s tangled brain
Using Facebook-like algorithms, a bespoke microscope, and hefty doses of patience, a team of scientists…
STAT+: Pharmalittle: FDA scientists say J&J Covid-19 shot is effective; vaccine makers predict big jump in deliveries this month
Good morning, everyone, and how are you today? We are doing just fine, thanks to…
New data shed light on efficacy of J&J’s single-dose vaccine against Covid-19
Scientists at the Food and Drug Administration said Wednesday that the single-shot Covid-19 vaccine developed…
STAT+: With genome-editing companies’ stock booming, Beam Therapeutics seizes its moment
Beam Therapeutics, a company focused on genome editing, is in a strange situation. The firm’s…
Opinion: Three steps can help companies speed FDA approval of new drugs
Drug developers see Food and Drug Administration approval as a difficult uphill climb, requiring large…
Opinion: Vaccine equity: If we build it, will they come?
In partnership with the federal government, California launched two massive Covid-19 vaccination sites this week….
How Covid-19 could usher in a new role for continuous glucose monitoring in hospitals
In early May, a wing of Ohio State University’s Wexner Medical Center was eerily empty….
Backed by Google, epidemiologists launch a sweeping Covid-19 data platform
Last January, Samuel Scarpino wasn’t sure what to make of Covid-19. The director of Northeastern…
STAT+: OpenBiome to wind down stool bank operations
OpenBiome, the nation’s first public stool bank, will soon end its program for collecting, screening,…